...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: Booyah ! I told you all!!

Agreed Bfw. EagleEyeCap's last post was logged as a violation of Agoracom rules and he/she has been warned. Proximity to database lock has no bearing on success or failure of BETonMACE. Back on April 18th, Resverlogix expected 2 to 4 months for trial wrap up. We aren't even a month in yet. Seems like EagleEye is showing his/her true colors.


New Message
Please login to post a reply